文献速递瓣膜外科

微创二尖瓣修复中二次阻断:预测因素与结局

Second cross-clamp in less invasive mitral valve repair for degenerative mitral regurgitation: Predictors and outcomes.
PubMed 文献 · J Thorac Cardiovasc Surg · 2025-07-28

基于Mini Mitral国际注册研究4577例退行性二尖瓣反流微创修复患者,二次阻断发生率为2.8%(128例),原因包括残余病变(71.9%)和收缩期前向运动(28.1%)。二次阻断与呼吸功能不全风险增加(OR 4.6)和ICU停留延长(β=0.35)相关,但与死亡率或主要术后并发症无关。双叶脱垂(OR 2.21)和预测SAM风险(OR 3.04)是二次阻断的危险因素。

要点

  • 二次阻断发生率2.8%,多因残余病变或SAM,再修复成功率81.3%。
  • 双叶脱垂和预测SAM风险是二次阻断的独立危险因素。
  • 二次阻断增加呼吸功能不全和ICU停留延长风险,但不增加死亡率。

核心结论

  • 微创二尖瓣修复中二次阻断不常见但可能发生,多数再修复成功,与呼吸功能不全和ICU停留延长相关。

研究设计与样本

  • 回顾性队列研究,基于Mini Mitral国际注册数据库,纳入4577例退行性二尖瓣反流行微创二尖瓣修复的患者。

主要发现

  • 二次阻断发生128例(2.8%),原因包括残余病变71.9%(n=92)和SAM 28.1%(n=36)。
  • 再修复104例(81.3%),置换24例(18.7%);再修复后94.9%患者无或轻度MR。
  • 双叶脱垂(OR 2.21)和预测SAM风险(OR 3.04)是二次阻断的危险因素。
  • 二次阻断与呼吸功能不全风险增加(OR 4.6)和ICU停留延长(β=0.35)相关。
  • 二次阻断与死亡率或主要术后并发症无关联。

临床怎么用

  • 对双叶脱垂或预测SAM风险高的患者,术前应充分评估并制定预案以减少二次阻断。
  • 发生二次阻断后应积极再修复,多数患者可避免瓣膜置换。
  • 术后需关注呼吸功能不全风险,可能需延长ICU监护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the incidence, echocardiographic patterns, operative strategies, and results of patients receiving a second cross-clamping in the large population of the Mini Mitral International Registry. METHODS: We examined 4577 patients with degenerative mitral regurgitation (MR) who underwent less invasive mitral repair. Patients with nondegenerative disease, planned valve replacement, and surgery without cross-clamping were excluded. Multivariable logistic regression model was applied to investigate predictors of second cross-clamping and the relationship between second cross-clamping and outcomes. RESULTS: Second cross-clamping was used in 128 cases (2.8%). Reasons for re-cross-clamping included residual pathology in 71.9% of the patients (n = 92) and systolic anterior motion (SAM) in 28.1% (n = 36). Re-repair was performed in 104 patients (81.3%), and replacement was performed in 24 (18.7%). After re-repair, 92 patients (94.9%) had no or mild MR, 4 patients (4.1%) had moderate MR, and 1 patient (1%) had severe MR. A residual SAM was observed in 2 patients (2.3%). Bileaflet prolapse (odds ratio [OR], 2.21) and predicted risk of SAM (OR, 3.04) were identified as risk factors for second cross-clamping. No association between second cross-clamping and mortality or major postoperative complications was found; however, second cross-clamping was associated with an increased risk of respiratory insufficiency (OR, 4.6) and longer intensive care unit (ICU) stay (β = 0.35). CONCLUSIONS: Second cross-clamping after less invasive mitral repair is infrequent but may be required, particularly in patients with bileaflet pathology or at increased risk of SAM. Most re-repairs were successful, with <20% of patients requiring replacement. Second cross-clamping was associated with higher risk of respiratory insufficiency and prolonged ICU stay.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Berretta P, Doenst T, Rinaldi M, et al. Second cross-clamp in less invasive mitral valve repair for degenerative mitral regurgitation: Predictors and outcomes. J Thorac Cardiovasc Surg. 2025. PMID: 40738217. doi:10.1016/j.jtcvs.2025.07.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。